Guardant Health, Inc. (GH)
Guardant Health, Inc. brought in $1.2B of revenue over the twelve months to June 30, 2026, up 42.7% from a year earlier. It posted a net loss of $453.4M. In fiscal 2025 capital spending exceeded operating cash flow by $233.1M. At June 30, 2026 it held $1.1B in cash against $1.5B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.
What Guardant Health, Inc. does
Guardant Health, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker GH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $982M | -$416.3M | -$3.32 | -$233.1M |
| 2024 | $739M | -$436.4M | -$3.56 | -$274.9M |
| 2023 | $563.9M | -$479.4M | -$4.28 | -$345.5M |
| 2022 | $449.5M | -$654.6M | -$6.41 | -$386.9M |
| 2021 | $373.7M | -$384.8M | -$4.00 | -$284.1M |
| 2020 | $286.7M | -$253.8M | -$2.60 | -$140.1M |
Latest SEC filings
What Guardant Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- July 30, 2026
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026
- July 30, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- June 18, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
- April 30, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about GH
What does Guardant Health, Inc. do?
Guardant Health, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker GH.
Is Guardant Health, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $453.4M on revenue of $1.2B.
How much revenue does Guardant Health, Inc. make?
Over the twelve months to June 30, 2026 Guardant Health, Inc. reported revenue of $1.2B. That is 42.7% more than a year earlier.
When did Guardant Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 22, 2026.
Similar companies
Follow GH
Get an email when Guardant Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow GH: get an email when it filesWhere the numbers come from
Financial figures are the values Guardant Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.